title: What is the significance of gynecologic symptoms in the participants in the NSABP study?
authors: William T
authors: WT
authors: Creasman
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000453:epidemiology*; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000453:epidemiology*
chemical_list: D013629:Tamoxifen; D020849:Raloxifene Hydrochloride